Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00286299 |
Recruitment Status :
Completed
First Posted : February 3, 2006
Last Update Posted : March 29, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Schizophrenia Cardiovascular Disease | Other: Aerobic high-intensity interval training (AIT) Other: Computer game training (CG) Other: Maximal strength training | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 33 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Physiological and Psychiatric Effects From Aerobic High Intensity Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia: A Controlled Clinical Trial. |
Actual Study Start Date : | October 2005 |
Actual Primary Completion Date : | July 2008 |
Actual Study Completion Date : | July 2008 |

Arm | Intervention/treatment |
---|---|
Experimental: Aerobic interval training (AIT)
AIT is 4x4 minutes interval training on a treadmill at 85 to 95 % HRpeak interspersed with 3 min of active resting periods at a work load corresponding to 70 % HRpeak between each interval. Patients performed the intervals walking or running with a minimum of 5 % inclination.
|
Other: Aerobic high-intensity interval training (AIT)
The AIT group trains 4x4 minute interval training on a treadmill at 85-95 % HRpeak interspersed with 3 minutes of active resting periods at a work load corresponding to 70% HRpeak between each interval. All training sessions are monitored and start with a 6 minute warm-up and end with a 5 minute cool-down period at a work load corresponding to 70% HRpeak. Intervals are performed walking or running on a treadmill with a minimum of 5% inclination, 3 times per week for 8 weeks.
Other Name: 4x4 interval |
Active Comparator: Computer game training (CG)
36 minutes playing supervised computer games, Tetris, Xbox
|
Other: Computer game training (CG)
The CG spend the same amount of time (36 minutes), training to improve their ability in the computer game, Tetris. Tetris is a game where small shapes called Tetraminoes fall from the top of the Playfield to the bottom. Players must rotate the Tetraminoes as they fall and fit them together to complete lines. When the player fills an entire line with blocks, that line is removed from the screen. If the player cannot complete lines, the blocks will eventually rise past the top of the screen, and the game ends.
Other Name: Tetris THQ Inc., Xbox, Microsoft |
Experimental: Maximal strength training (MST)
MST is performed in a leg press machine. The weight is lowered in a controlled manner in the eccentric phase until the patient reached 90 degrees in the knee joint. Then the patients has a short stop (~0.5 second) before the weight is moved as rapidly as possible to complete extension. The training volume is 4 sets of 4RM (i.e. 85-90 % 1RM). The training load is increased with 2.5-5 kg each time patients managed to perform 4 sets with the determined load or each training session.
|
Other: Maximal strength training
Training starts with a 10 minute warm-up on the treadmill. Maximal strength training is then performed in an inclined leg press machine. The subject lifts 4 maximal repetitions that are repeated 4 times after a 2 minute rest period. Subjects are instructed to lift the weight with an intention of maximal mobilization of force. Training load is increased each time the subject manage to perform 4x4 maximal repetitions. Training is carried out 3 times per week in 8 weeks.
Other Names:
|
- peak aerobic capacity (VO2peak) [ Time Frame: Pre- and Posttest ]
- Positive and Negative Syndrome Scale (PANSS) [ Time Frame: Pre- and Posttest ]
- Calgary Depression Scale for Schizophrenia (CDSS) [ Time Frame: Pre- and Posttest ]
- The 36-item short form (SF-36) [ Time Frame: Pre- and Posttest ]
- 60 Watt walking efficiency, Net efficiency [ Time Frame: Pre- and Posttest ]
- Maximal strength, measured as one repetition maximum (1RM) in a incline leg press machine (Technogym) [ Time Frame: Pre- and Post test ]
- Fasting blood samples, systolic and diastolic blood pressure. [ Time Frame: Pre- and posttest ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria: schizophrenia, schizotypal and delusional disorders (F20-F29) according to the international statistical classification of diseases and related health problems, 10th revision (ICD-10) prepared by the World Health Organization. Patients must have stable antipsychotic medication for six weeks prior to participation.
Exclusion criteria: coronary artery disease, chronic obstructive pulmonary disease, not being able to perform physical treadmill testing and exercise, and less than 80% compliance to the training sessions. All subjects go through a physical health examination at inclusion.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00286299
Norway | |
St. Olavs Hospital, Department of Psychiatry | |
Trondheim, Norway, 7041 |
Study Chair: | Geir Nilsberg, M.D. | Norwegian University og Science and Technology | |
Principal Investigator: | Jørn Heggelund, M.Sc. | Norwegian University of Science and Technology |
Publications of Results:
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT00286299 |
Other Study ID Numbers: |
4.2005.1507 |
First Posted: | February 3, 2006 Key Record Dates |
Last Update Posted: | March 29, 2017 |
Last Verified: | March 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Schizophrenia Cardiovascular disease Aerobic capacity Mortality Exercise |
Cardiovascular Diseases Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders |